The Angiopoietin Axis in Cancer
|
|
- Gloria Potter
- 6 years ago
- Views:
Transcription
1 Ang2 Ang1 The Angiopoietin Axis in Cancer Tie2
2 An Overview: The Angiopoietin Axis Plays an Essential Role in the Regulation of Tumor Angiogenesis Growth of a tumor beyond a limiting size is dependent upon its ability to undergo angiogenesis. 1,2 Angiogenesis is a complex process resulting from the input of multiple signaling pathways. 1,3 One such pathway is the angiopoietin axis, which is a separate and distinct pathway from the vascular endothelial growth factor (VEGF) axis, and consists of the ligands angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2) and their receptor, Tie2. 3,4 These molecules control tumor angiogenesis by regulating endothelial cell survival, proliferation, and migration. 5 Ang1 and Ang2 have distinct functions in the regulation of tumor angiogenesis. 6 Tie2 signaling is activated by Ang1, resulting in stabilization and maintenance of vessel integrity. 6 Ang2, on the other hand, is a natural antagonist of the Ang1/Tie2 interaction and prevents Ang1-mediated vessel normalization and remodeling, leading to new vessel sprouting. 6 As the angiopoietins play a distinct role in modulating tumor angiogenesis, the angiopoietin axis may represent a potential pathway for therapeutic strategy in cancer. Ang1 SURVIVAL Ang2 Tie2 PROLIFERATION MIGRATION Tumor Angiogenesis
3 Tumor Growth Requires a Dedicated Blood Supply Achieved Through the Angiogenic Switch Tumors require a dedicated blood supply to provide oxygen and nutrients essential for tumor cell survival and growth. 1,2 New tumor blood vessels form through angiogenesis, a complex process resulting from the concerted actions of many distinct signaling pathways. 1,3 Angiogenesis is triggered in tumors via the angiogenic switch, which occurs when the actions of proangiogenic factors outweigh those of antiangiogenic factors. 1 This is frequently achieved through altered expression of genes that are key regulators of angiogenesis, resulting in overproduction and secretion of proangiogenic molecules such as VEGF, basic fibroblast growth factor (bfgf), platelet-derived growth factor (PDGF), and Ang2, or conversely through the decreased expression of antiangiogenic molecules such as thrombospondin-1. 1,3 Unlike normal blood vessels, tumor vasculature is structurally and functionally abnormal, exhibiting heterogeneity, irregularity, incomplete pericyte coverage, disorganized cell junctions, and nonuniform blood flow. 2,7 These abnormalities produce leaky vessels, providing a pathway for tumor cells to gain access to the systemic circulation and to metastasize to distant tissue sites. 8 Pericyte
4 Ang1 Ang2 The Angiopoietin Axis Regulates Tumor Angiogenesis by Controlling Endothelial Cell Survival, Proliferation, and Migration The angiopoietin axis consists of the ligands Ang1 and Ang2 and their receptor Tie2. 4 Tie2 is expressed predominantly on endothelial cells and is activated by the binding of Ang1, which is secreted primarily by vascular smooth muscle cells and pericytes. 4 Tie2 may also be bound by Ang2, which is secreted predominantly by endothelial cells and is generally found in tissues undergoing vascular remodeling. 4 Activation of Tie2 stimulates receptor autophosphorylation, triggering downstream signal transduction cascades such as PI3K/Akt and Ras/MAPK to regulate endothelial cell survival, motility, and proliferation. 5,6,9 Tie2 SURVIVAL PROLIFERATION MIGRATION
5 The Angiopoietin Axis Controls a Wide Range of Endothelial Activities That Impact Tumor Vascular Architecture Although Ang1 and Ang2 both bind the Tie2 receptor, they exhibit distinct functions in tumor vascular remodeling. 2,6 Ang1 binding stimulates Tie2 signaling to normalize and maintain the integrity of blood vessels through organization of cell junctions, restoration of pericyte coverage, and the formation of linear, nonleaky vessels. 2,6,10 Conversely, Ang2 has been described as a natural antagonist to the Ang1/Tie2 interaction; binding of Ang2 to Tie2 results in destabilization of blood vessels, increased vessel permeability, and stimulation of new vessel sprouting. 2,6,9 However, in some context-dependent scenarios, Ang2 can act as a Tie2 agonist or functions independently of Tie2 by interacting with integrins, fibronectin, and laminins to promote endothelial cell proliferation, migration, and adhesion. 9,11-13 The clinical relevance of this pathway in cancer is highlighted by the finding that Tie2 is upregulated during tumor angiogenesis and higher levels of Ang2 relative to Ang1 correlate with poor prognosis in various cancers, including breast, metastatic colorectal, hepatocellular, and ovarian. 2,4,9 Function dependent upon binding to Tie2 Ang1 Ang2 Tie2 agonist Tie2 antagonist Promotes stabilization of blood Destabilizes quiescent vessels to vessels through development prepare for new vessel sprouting of linear, non-leaky vessels, Tie2 agonist when: organized endothelial junctions, Ang1 is absent and pericyte coverage Tie2 levels are elevated Ang1 Normalized Vessels Ang2 Ang2 blocks the vesselstabilizing actions of Ang1 and induces rapid formation of new, abnormal vessels Tie2-independent function None described Interacts with integrins to promote endothelial cell proliferation and migration
6 The Ability of Angiopoietins to Regulate Lymphangiogenesis May Also Contribute to Tumor Metastasis In addition to its role in regulating blood vessel formation, the angiopoietin axis is required for normal lymphangiogenesis, as demonstrated by the dysfunctional lymphatic systems of mice harboring a genetic deletion of Ang2. 14 Unlike their naturally opposing roles in angiogenesis, Ang1 and Ang2 both promote normal lymphatic vessel patterning and function, as evidenced by the ability of Ang1 to rescue the lymphatic vessel defects in Ang2-deficient mice. 9,14 Compromising the integrity of the lymphatic vasculature can lead to leaky vessels that may facilitate tumor cell dissemination and metastasis to distant sites. 13 This concept is supported by studies in preclinical tumor models, where Ang2 overexpression increased tumor lymphatic vessel density and enhanced invasive growth and the rate of lymphatic metastasis. 13 Lymphatic Vessels Metastasis to Lymph Nodes MedicalRF.com/MedicalRF.com/Getty Images
7 Regulation of Angiogenesis May Represent a Potential Therapeutic Strategy for Cancer Angiogenesis is necessary for tumor growth and is a complex process involving multiple signaling cascades. 3 Regulation of this process thus represents a rational therapeutic strategy against many tumor types, including ovarian, colon, renal, hepatocellular, and non-small cell lung cancers. 3,15,16 The VEGF axis acts to stimulate endothelial cell growth in tumor angiogenesis and has therefore emerged as a potential pathway for intervention. 8 However, evasive mechanisms may permit tumors to grow and progress despite aims to prevent VEGF signaling, reflecting the existence of alternative proangiogenic pathways beyond the VEGF axis. 15 The angiopoietin axis represents a separate pathway from the VEGF axis and plays a distinct role in mediating tumor angiogenesis by interacting with Tie2 and affecting vascular remodeling. 3,9 Thus, the role of alternative pathways involved in mediating tumor angiogenesis is of importance and is being actively investigated. 9,15 Normalized Vessels Tumor Relapse Due to Resistance to VEGF Pathway Inhibitors Abnormal Vessels
8 Vascular Remodeling in Tumors Is Influenced by the Balance Between Ang1 and Ang2 Preclinical studies have demonstrated that tumor vasculature and tumor growth are sensitive to the relative balance between Ang1 and Ang2 expression. If Ang2 expression predominates, the vasculature shows defects that typify tumor vessels, including poor contacts between endothelial cells, diffuse staining of endothelial cell junction proteins, and weakened association with pericytes whose numbers may be reduced If Ang1 expression predominates, the vasculature is normalized, as reflected by tight contacts between endothelial cells, linear staining of endothelial cell junction proteins at the cell borders, and tight associations with pericytes. 17,20,21 The clinical impact of tumor vessel normalization is currently unknown, and further investigation is warranted. Expression of Ang2 > Ang1 Expression of Ang1 > Ang2
9 Summary: The Angiopoietin Axis in Cancer A Key Regulator of Tumor Angiogenesis Ang1 Ang2 Tumor angiogenesis is necessary for tumors to grow beyond a limiting size. 1,2 Angiogenesis is initiated by the angiogenic switch, which involves a complex array of signaling molecules, such as VEGF, PDGF, and angiopoietins, acting on multiple cell types. 1,3 Evasive mechanisms may permit tumors to grow and progress despite aims to prevent VEGF signaling, reflecting the existence of alternative proangiogenic pathways. 15 The angiopoietin axis represents a separate pathway with distinct functions from the VEGF axis. 3,9 Signaling via the angiopoietin axis, comprised of the ligands Ang1 and Ang2 and the Tie2 receptor, is essential for tumor angiogenesis, regulating a wide range of endothelial cell activities that impact tumor vascular architecture. 4,5,9 Additionally, the ability of angiopoietins to regulate lymphangiogenesis may also contribute to tumor metastasis. 9,13,14 Thus, angiopoietins play a distinct role in modulating tumor angiogenesis. As a result, the angiopoietin axis may represent a potential pathway for therapeutic strategy in cancer. SURVIVAL Tie2 PROLIFERATION MIGRATION Tumor Angiogenesis
10 References 1. Hanahan D, et al. Cell. 2000;100: Metheny-Barlow LJ, et al. Cell Res. 2003;13: Folkman J. Nat Rev Drug Discov. 2007;6: Thomas M, et al. Angiogenesis. 2009;12: Augustin HG, et al. Nat Rev Mol Cell Biol. 2009;10: Eklund L, et al. Exp Cell Res. 2006;312: Nagy JA, et al. Br J Cancer. 2009;100: Herbst RS. Expert Opin Emerg Drugs. 2006;11: Huang H, et al. Nat Rev Cancer. 2010;10: Saharinen P, et al. Nat Cell Biol. 2008;10: Yuan HT, et al. Mol Cell Biol. 2009,29: Woolf AS, et al. J Am Soc Nephrol. 2009;20: Schulz P, et al. FASEB J. 2011;25: Gale NW, et al. Dev Cell. 2002;3: Bergers G, et al. Nat Rev Cancer. 2008;8: Eskander RN, et al. Biologics. 2011;5: Falcón BL, et al. Am J Pathol. 2009;175: Cao Y, et al. Cancer Res. 2007;67: Reiss Y, et al. J Pathol. 2009;217: Tian S, et al. Br J Cancer. 2002;86: Stoeltzing O, et al. Cancer Res. 2003;63: Notes
11 Notes Notes
12 Notes Sleeve
13 Current as of February Statements in this booklet are based on the company s current beliefs and Amgen disclaims any duty to update. For more information about Amgen and its business, including risks and uncertainties, please refer to Amgen s filings with the US Securities & Exchange Commission. Provided as an educational resource. Do not copy or distribute Amgen Inc. All rights reserved. G65614-R1-V R1-V1
The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis
The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis Nam Deuk Kim, Ph.D. Pusan National University Contents Part 1. The process of angiogenesis Part 2. The role of angiopoietins
More information1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications
Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the
More information1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?
1. The metastatic cascade 3. Pathologic features of metastasis 4. Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of Paget s disease of the nipple (intraductal
More informationSignaling Vascular Morphogenesis and Maintenance
Signaling Vascular Morphogenesis and Maintenance Douglas Hanahan Science 277: 48-50, in Perspectives (1997) Blood vessels are constructed by two processes: vasculogenesis, whereby a primitive vascular
More informationNeoplasia 18 lecture 8. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 8 Dr Heyam Awad MD, FRCPath ILOS 1. understand the angiogenic switch in tumors and factors that stimulate and inhibit angiogenesis. 2. list the steps important for tumor metastasis
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationAngiogenesis as a therapeutic target
Angiogenesis as a therapeutic target Lecture Experimentelle Krebsforschung SS 07 Prof. Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences University of
More informationMechanisms of Resistance to Antiangiogenic. Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012
Mechanisms of Resistance to Antiangiogenic Agents Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012 Angiogenesis: A fundamental attribute of cancer Premise of Anti-angiogenic
More informationPATHOBIOLOGY OF NEOPLASIA
PATHOBIOLOGY OF NEOPLASIA Department of Pathology Gadjah Mada University School of Medicine dr. Harijadi Blok Biomedis, 6 Maret 2009 [12] 3/17/2009 1 The pathobiology of neoplasia Normal cells Malignant
More informationHeterotypy and Angiogenesis
Heterotypy and Angiogenesis Tumors are perpetual wounds 1. Normally stroma and epithelia converse at a distance. 2. Juxtaposition of stroma and epithelia is indicative of tissue damage. 4. Activate strategies
More informationAngiogenesis in Human Development. Vascular Development
Angiogenesis in Human Development Jan Kitajewski ICRC 217B, ph 851-4688, email: jkk9 BACKGROUND READING: Vascular Development Signaling Vascular Morphogenesis and Maintenance Douglas Hanahan. Science 277:
More informationInflammatory Cells and Metastasis
Inflammatory Cells and Metastasis Experimentelle Krebsforschung SS 07 Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences Center of Biomedicine University
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,
More informationOpposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation Minah Kim,, Gavin Thurston, Donald M. McDonald J Clin Invest. 2016;126(9):3511-3525. https://doi.org/10.1172/jci84871. Research
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD
More informationAngiogenesis in Ovarian Cancer
Angiogenesis in Ovarian Cancer Dr Shibani Nicum Consultant Medical Oncologist and Lead for Gynae- Oncology Oxford University Hospitals Content 1. Epithelial Ovarian Cancer : epidemiology 2. Angiogenesis-normal
More informationTargeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
Article Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2 Graphical Abstract Authors Doruk Keskin, Jiha Kim,..., Raghu Kalluri, Valerie S. LeBleu Correspondence
More informationPractice of Medicine-1 Ovarian Cancer Clinical Correlation
Practice of Medicine-1 Ovarian Cancer Clinical Correlation Amir A. Jazaeri, M.D. Assistant Professor, Division of Gynecologic Oncology American Cancer Society Female Cancers 2000 Statistics Reprinted by
More informationTumor Associated Macrophages as a Novel Target for Cancer Therapy
Tumor mass Tumor Associated Macrophage Tumor Associated Macrophages as a Novel Target for Cancer Therapy This booklet contains forward-looking statements that are based on Amgen s current expectations
More informationNintedanib in Oncology Backgrounder
For media outside the US, UK and Canada only Nintedanib in Oncology Backgrounder 1. What is nintedanib? 2. How does nintedanib work? 3. Data overview 4. Additional clinical data 5. Nintedanib approval
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationThe Hallmarks of Cancer
The Hallmarks of Cancer Theresa L. Hodin, Ph.D. Clinical Research Services Theresa.Hodin@RoswellPark.org Hippocrates Cancer surgery, circa 1689 Cancer Surgery Today 1971: Nixon declares War on Cancer
More informationHEM- AND LYMPH- ANGIOGENESIS IN CANCER METASTASIS
From THE DEPARTMENT OF MICROBIOLOGY, TUMOR AND CELL BIOLOGY Karolinska Institutet, Stockholm, Sweden HEM- AND LYMPH- ANGIOGENESIS IN CANCER METASTASIS Hong Ji Stockholm 2013 All previously published papers
More informationTumor microenvironment Interactions and Lung Cancer Invasiveness. Pulmonary Grand Rounds Philippe Montgrain, M.D.
Tumor microenvironment Interactions and Lung Cancer Invasiveness Pulmonary Grand Rounds Philippe Montgrain, M.D. February 26, 2009 Objectives Review epithelial mesenchymal transition (EMT), and its implications
More informationSupplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis
Supplementary Materials for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis 1 Supplementary Figure Legends Supplementary Figure 1: Integrin expression
More informationSIBLINGs, cancer's multifunctional weapons
SIBLINGs, cancer's multifunctional weapons 6/18/08 Akeila Bellahcène and Vincent Castronovo of the Metastasis Research laboratory of the University of Liège are among the first researchers to have discovered
More informationCancer Biology Course. Invasion and Metastasis
Cancer Biology Course Invasion and Metastasis 2016 Lu-Hai Wang NHRI Cancer metastasis Major problem: main reason for killing cancer patients, without it cancer can be cured or controlled. Challenging questions:
More informationTissue repair. (3&4 of 4)
Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid
More informationA Comparison of Endothelial Cell-Selective Adhesion Molecule and von Willebrand Factor Expression in Breast Cancer Growth and Metastasis
Original Article Middle East Journal of Cancer; April 2018; 9(2): 85-90 A Comparison of Endothelial Cell-Selective Adhesion Molecule and von Willebrand Factor Expression in Breast Cancer Growth and Metastasis
More informationVascular Endothelial Growth Factor Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma
OMPJ Vascular Endothelial Growth Factor Expression in Oral Epithelial Dysplasia 10.5005/jp-journals-10037-1003 and Oral Squamous Cell Carcinoma ORIGINAL RESEARCH Vascular Endothelial Growth Factor Expression
More informationDisorders of Cell Growth & Neoplasia. Lecture 4 Molecular basis of cancer
General Pathology VPM 152 Disorders of Cell Growth & Neoplasia Lecture 4 Molecular basis of cancer Enrique Aburto Apr 2010 Skin tumor in a 10-year-old Rottweiler. Considering the external appearance and
More information!!! Oncology for Scientists (RPN 530) Metastasis and Angiogenesis Chapter 13 and 14 Oct. 28 th 2014
Oncology for Scientists (RPN 530) Metastasis and Angiogenesis Chapter 13 and 14 Oct. 28 th 2014 Department of Cancer Genetics Masashi Muramatsu, Ph.D. About Exam First, think and understand the concepts.
More informationIn vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG)
In vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG) 1 Dr Saeb Aliwaini 13/11/2015 Migration in vivo Primary tumors are responsible for only about 10%
More informationNEWS RELEASE Media Contact: Megan Pace Investor Contact: Kathee Littrell Patient Inquiries: Ajanta Horan
NEWS RELEASE Media Contact: Megan Pace 650-467-7334 Investor Contact: Kathee Littrell 650-225-1034 Patient Inquiries: Ajanta Horan 650-467-1741 GENENTECH RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR
More informationAward Number: W81XWH TITLE: PRINCIPAL INVESTIGATOR: Michael Dellinger
AD Award Number: W81XWH-10-1-0052 TITLE: PRINCIPAL INVESTIGATOR: Michael Dellinger CONTRACTING ORGANIZATION: UT Southwestern Medical Center Dallas, TX 75390 REPORT DATE: February 2013 TYPE OF REPORT: Annual
More informationVascular Endothelial Growth Factor in Human Colon Cancer: Biology and Therapeutic Implications
Vascular Endothelial Growth Factor in Human Colon Cancer: iology and Therapeutic Implications LEE M. ELLIS, YUTK TKHSHI, WENIO LIU, RYMOND M. SHHEEN University of Texas M.D. nderson Cancer Center, Departments
More informationVascular Basement Membrane Components in Angiogenesis An Act of Balance
Directions in Science TheScientificWorldJOURNAL (2008) 8, 1246 1249 ISSN 1537-744X; DOI 10.1100/tsw.2008.155 Vascular Basement Membrane Components in Angiogenesis An Act of Balance Lars Jakobsson 1, *
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-04-1-0618 TITLE: Are Breast Tumor Stem Cells Responsible for Metastasis and Angiogenesis PRINCIPAL INVESTIGATOR: Quintin Pan, Ph.D. CONTRACTING ORGANIZATION: University of Michigan
More informationCitation: Chen, Wei (2015) Modelling of Tumour-induced Angiogenesis. Doctoral thesis, Northumbria University.
Citation: Chen, Wei (2015) Modelling of Tumour-induced Angiogenesis. Doctoral thesis, Northumbria University. This version was downloaded from Northumbria Research Link: http://nrl.northumbria.ac.uk/30235/
More informationLYMPHANGIOGENESIS REVIEWS THE EMERGENCE OF MOLECULAR AND TRANSGENIC LYMPHOLOGY: WHAT DO WE (REALLY) KNOW SO FAR?
1 Lymphology 39 (2006) 1-7 LYMPHANGIOGENESIS REVIEWS THE EMERGENCE OF MOLECULAR AND TRANSGENIC LYMPHOLOGY: WHAT DO WE (REALLY) KNOW SO FAR? C. Suri Independent Biotechnology Consultant,* Tarrytown, New
More informationFor personal use only
ASX and Media release 6 April 211 Circadian s Inhibits Tumour Growth in Models of Lung, Ovarian and Prostate Cancer Data demonstrates efficacy of with other therapeutic agents in mouse models of lung,
More informationDAWNING OF THE AGE OF ANGIOGENESIS
DAWNING OF THE AGE OF ANGIOGENESIS Bob Leibowitz, M.D. DIPLOMATE AMERICAN BOARDS OF INTERNAL MEDICINE AND SUBSPECIALTIES OF MEDICAL ONCOLOGY AND HEMATOLOGY December 1997 April 2004 (Revised) Angiogenesis
More informationColorectal Cancer Therapy and Associated Toxicity
Colorectal Cancer Therapy and Associated Toxicity Mountain States Cancer Conference November 6, 2010 Colin D. Weekes, M.D., Ph.D Assistant Professor University of Colorado GI Cancers Are Common 2009 Estimated
More informationProcessing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis
Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis ii Colloquium Digital Library of Life Sciences This e-book is an original work
More informationAngiogeneza sprawa Ŝycia lub śmierci
Angiogeneza sprawa Ŝycia lub śmierci Carmeliet, Nature 2000 vascular system veins (3 cm) arteries (0.5 cm) capillaries (6 µm) arterioles (30 µm) Schematic structure of capillary Endothelium regulates:
More informationCancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz
Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz December 1, 2010 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 25 More mutations as 20 you get older
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/28967 holds various files of this Leiden University dissertation. Author: Palm, Margaretha Maria (Margriet) Title: High-throughput simulation studies of
More informationulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236
Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine
More informationVIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer
VIII Curso Internacional del PIRRECV Some molecular mechanisms of cancer Laboratorio de Comunicaciones Celulares, Centro FONDAP Estudios Moleculares de la Celula (CEMC), ICBM, Facultad de Medicina, Universidad
More informationAnti-angiogenesis in cancer; met and unmet goals - an interview with Robert Kerbel
Int. J. Dev. Biol. 55: 395-398 doi: 10.1387/ijdb.103217fb www.intjdevbiol.com Anti-angiogenesis in cancer; met and unmet goals - an interview with Robert Kerbel FRANCESCO BERTOLINI* Laboratory of Hematology-Oncology,
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 21 Done by Ahmad Rawajbeh Corrected by Omar Sami Doctor Maha Shomaf Ability to Invade and Metastasize The metastatic cascade can be subdivided into two phases: 1-invasion of ECM and vascular dissemination:
More informationVirtual Melanoma: When, Where and How Much to Cut Yang Kuang, Arizona State University
Virtual Melanoma: When, Where and How Much to Cut Yang Kuang, Arizona State University Based on: Eikenberry S, Thalhauser C, Kuang Y. PLoS Comput Biol. 2009, 5:e1000362. Mathematical Modeling of Melanoma
More informationCancer as a disease of development; Developmental therapies: Anti- Angiogenesis; Stem cells and tissue regeneration.
Cancer as a disease of development; Developmental therapies: Anti- Angiogenesis; Stem cells and tissue regeneration Mitesh Shrestha What is Cancer? Unrestricted cell growth: tumor cell population 1x10^9
More informationVascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis
Original papers Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis Aydan Eroğlu 1, A F, Cevriye Ersöz 2,
More informationAngiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System
Japan-Mexico Workshop on Pharmacology and Nanobiology Feb. 25, 2009; Universidad Nacional Autönoma de Mëxico, Mexico City Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System Shigetomo
More informationPopperian Pathways: the demarcation between quack cancer cures and scientific remedies. Michael Baum UCL November 2007
Popperian Pathways: the demarcation between quack cancer cures and scientific remedies Michael Baum UCL November 2007 The Philosophy of Science: Karl Popper and me 1993 Inductive Logic Observations Hypothesis
More informationCombination Therapy with Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial
Combination Therapy with Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial Jeffrey S. Heier, MD On behalf of the RUBY Investigators Ophthalmic Consultants of Boston
More informationEffect of a nutrient mixture on the localization of extracellular matrix proteins in HeLa human cervical cancer xenografts in female nude mice
Effect of a nutrient mixture on the localization of extracellular matrix proteins in HeLa human cervical cancer xenografts in female nude mice Publication from the Dr. Rath Research Institute Experimental
More informationCancer Metronomic Therapy Milan, February 26, 2016
Cancer Metronomic Therapy Milan, February 26, 2016 Metronomic Chemotherapy: Evolution and Development of the Concept Robert S. Kerbel, PhD Senior Scientist Sunnybrook Research Institute Professor, Dept.
More informationRIP-Tag2 mouse model as a Paradigm for Target. Search in NETs
RIP-Tag2 mouse model as a Paradigm for Target Search in NETs Oriol Casanovas, Ph.D. Tumor Angiogenesis Group INSTITUT CATALÀ d ONCOLOGIA IDIBELL Barcelona (SPAIN) Therapeutic Targeting of the Tumor Stroma
More informationGeneral Pathology VPM 152. Disorders of Cell Growth & Neoplasia. Lecture 4 Molecular basis of cancer
General Pathology VPM 152 Disorders of Cell Growth & Neoplasia Lecture 4 Molecular basis of cancer Enrique Aburto http://people.upei.ca/eaburto Winter 2015 Molecular Basis of Cancer Fundamental principles
More informationLECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE
LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE - Small intestine in humans is around 3-4 metres long - Internal surface of the small intestines are lined by villi o Villi are composed of absorptive cells (epithelial/enterocytes)
More informationA Changing Paradigm: Cancer Metastasis as the Target
A Changing Paradigm: Cancer Metastasis as the Target What are we going to cover today? Review What is cancer? How is it typically attacked? From www.dslrf.org Science Friday March 14, 2014 Jon R. Wiener,
More informationOpposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation Minah Kim, 1 Breanna Allen, 1 Emilia A. Korhonen, 2 Maximilian Nitschké, 1 Hee Won Yang, 3 Peter Baluk, 1 Pipsa Saharinen, 2 Kari
More informationCELL BIOLOGY - CLUTCH CH CANCER.
!! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined
More informationMicroenvironmental influence on angiogenesis and tumor cell survival. Mark W. Dewhirst, DVM, PhD Duke University Medical Center
Microenvironmental influence on angiogenesis and tumor cell survival Mark W. Dewhirst, DVM, PhD Duke University Medical Center Angiogenic Switch Tumor-host cell interactions Endothelial cell Macrophage
More informationAnimal Tissue Culture SQG 3242 Biology of Cultured Cells. Dr. Siti Pauliena Mohd Bohari
Animal Tissue Culture SQG 3242 Biology of Cultured Cells Dr. Siti Pauliena Mohd Bohari The Culture Environment Changes of Cell s microenvironment needed that favor the spreading, migration, and proliferation
More informationTransformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused
More informationTumor Angiogenesis: Determined By VEGF Expression, MAGS Scoring, Doppler Study, As Prognostic Indicator In Carcinoma Breast
ISPUB.COM The Internet Journal of Surgery Volume 8 Number 1 Tumor Angiogenesis: Determined By VEGF Expression, MAGS Scoring, Doppler Study, As Prognostic Indicator In Carcinoma Breast R Shankar, S Tiwary,
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF GASTRIC CARCINOMAS SUMMARY Scientific Coordinator: Univ. Prof. Dr. SIMIONESCU CRISTIANA EUGENIA
More informationAngiogenesis and Metastasis
Angiogenesis and Metastasis 10/31/2017 Tariq Bhat (Ph.D.) Definition of Angiogenesis: Formation of new blood vessels/capillaries from the pre-existing vessels/capillaries Involves - sprouting - splitting
More informationDisorders of Cell Growth & Neoplasia
General Pathology VPM 152 Disorders of Cell Growth & Neoplasia Lecture 3 Rate of growth, local invasion, and metastasis. Molecular basis of cancer (normal cell-cycle and cellular proliferation). Enrique
More informationI TESSUTI: Dott.ssa Liliana Belgioia Università degli Studi di Genova
I TESSUTI: 1. Repair, Radiosensitivity, Recruitment, Repopulation, Reoxygenation 2. Acute and chronic hypoxia 3. Tissue microenvironment and tissue organization Dott.ssa Liliana Belgioia Università degli
More informationRESEARCH ARTICLE. Endostar Combined with Cisplatin Inhibits Tumor Growth and Lymphatic Metastasis of Lewis Lung Carcinoma Xenografts in Mice
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.5.3079 RESEARCH ARTICLE Endostar Combined with Cisplatin Inhibits Tumor Growth and Lymphatic Metastasis of Lewis Lung Carcinoma Xenografts in Mice Xiao-Peng
More informationOverview of primary HHV-8 infection
Overview of primary HHV-8 infection HHV-8, also known as Kaposi sarcoma-associated herpesvirus (KSHV), is a gamma herpesvirus primarily transmitted through saliva. The virus initially replicates in epithelial
More informationAngiogenesis-A Biochemical/Mathematical Prospective
Angiogenesis-A Biochemical/Mathematical Prospective Howard A. Levine and Marit Nilsen-Hamilton Abstract. Angiogenesis, the formation of new blood vessels from an existing vasculature, is a complex biochemical
More informationOxygen-independent regulation of HIF-1α levels
Oxygen-independent regulation of HIF-1α levels Growth factors THIOREDOXIN (TRX) OXIDATIVE STRESS PKC PI3K Akt mtor PTEN HIF1α p70s6k Target gene mrnas SP1 HIF-1α mrna Intratumor hypoxia Genetic alterations
More informationFrom Jon R. Wiener, Ph.D. Associate Dean, Arts and Sciences A-B Tech
A Changing Paradigm: Cancer Metastasis as the Target From www.dslrf.org Jon R. Wiener, Ph.D. Associate Dean, Arts and Sciences A-B Tech What are we going to cover today? This is more an opinion piece than
More informationTITLE: Notch in Pathological Angiogenesis and Lymphangiogenesis
Award Number: W81XWH-10-1-0304 TITLE: Notch in Pathological Angiogenesis and Lymphangiogenesis PRINCIPAL INVESTIGATOR: Minji Kim CONTRACTING ORGANIZATION: Columbia University New York, NY 10032 REPORT
More informationTargeting tumour associated macrophages in anti-cancer therapies. Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018
Targeting tumour associated macrophages in anti-cancer therapies Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018 Macrophages: Professional phagocytes of the myeloid lineage APC,
More informationLYMPHANGIOGENESIS REVIEWS THE RELATIONSHIP BETWEEN TUMORS AND THE LYMPHATICS: WHAT MORE IS THERE TO KNOW?
62 Lymphology 39 (2006) 62-68 LYMPHANGIOGENESIS REVIEWS THE RELATIONSHIP BETWEEN TUMORS AND THE LYMPHATICS: WHAT MORE IS THERE TO KNOW? J.P. Sleeman Forschungszentrum Karlsruhe, Institut für Toxikologie
More informationProfessor Harvey White. Interventional Cardiologist Auckland
Professor Harvey White Interventional Cardiologist Auckland Stem cells and the heart Harvey White Director of Coronary Care Unit and Cardiovascular Research Unit Green Lane Cardiovascular Service Auckland
More informationLecture Outline. Hormones & Chemical Signaling. Communication Basics: Overview. Communication Basics: Methods. Four methods of cell communication
Lecture Outline Hormones & Chemical Signaling Communication Basics Communication Overview Communication Methods Signal pathways Regulation (modulation) of signal pathways Homeostasis... again Endocrine
More informationIntro to Cancer Therapeutics
An Intro to Cancer Therapeutics Christopher R. Chitambar, MD Professor of Medicine Division of Hematology & Oncology Froedtert and Medical College of Wisconsin Clinical Cancer Center cchitamb@mcw.edu Intro
More informationSmall Molecule Inhibitor of the Wnt Pathway (SM04755) as a Potential Topical Scleroderma Treatment
Small Molecule Inhibitor of the Wnt Pathway (SM755) as a Potential Topical Scleroderma Treatment Vishal Deshmukh, PhD, Allison Hood, Yusuf Yazici, MD Disclosures Vishal Deshmukh, Ph.D. o Financial disclosure:
More informationIntegrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma
Huang and Rofstad Journal of Experimental & Clinical Cancer Research (2018) 37:92 https://doi.org/10.1186/s13046-018-0763-x REVIEW Integrins as therapeutic targets in the organ-specific metastasis of human
More informationR J M E Romanian Journal of Morphology & Embryology
Rom J Morphol Embryol 2012, 53(3 Suppl):749 753 ORIGINAL PAPER R J M E Romanian Journal of Morphology & Embryology http://www.rjme.ro/ The characterization of PDGFR-alpha and PDGFR-beta expression in malignant
More informationReview Article Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology
e Scientific World Journal, Article ID 919570, 16 pages http://dx.doi.org/10.1155/2014/919570 Review Article Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology C. Benazzi,
More informationChapter 6. Villous Growth
Core Curriculum in Perinatal Pathology Chapter 6 Villous Growth Overview of vasculogenesis and angiogenesis Vasculogenesis Extraembryonic Vasculogenesis Angiogenesis Branching angiogenesis Sprouting angiogenesis
More informationCancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013
Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz October 11, 2013 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 200 180 160 140 120 100 80 60 40
More informationSupplemental Material
Supplemental Material Supplementary Fig. 1. EETs stimulate primary tumor growth. a) Schematic presentation of genetic and pharmacological tools used to manipulate endogenous EET levels. b) Endothelial
More informationRole of Cancer Microenvironment in Metastasis: Focus on Colon Cancer
Cancer Microenvironment (2008) 1:69 83 DOI 10.1007/s12307-008-0007-2 REVIEW PAPER Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer Stéphanie Gout & Jacques Huot Received: 22 December
More informationEffects of Ionizing Radiation on Normal and Tumor-Associated Lymphatic Vessels
Effects of Ionizing Radiation on Normal and Tumor-Associated Lymphatic Vessels By Jennifer D. Lobo Submitted to the Department of Nuclear Science and Engineering In partial fulfillment of the requirements
More informationPart I. An Introduction to Cancer
Part I An Introduction to Cancer 2 Chapter 1 Cancer: Descriptive Overview Cancer is a disease in which cells propagate uncontrollably. These cells can come from many different parts of the body and the
More informationPersonalized medicine by the use of mathematical models for angiogenesis: validation in a Mesenchymal Chondrosarcoma patient
Personalized medicine by the use of mathematical models for angiogenesis: validation in a Mesenchymal Chondrosarcoma patient Agur Zvia Institute for Medical BioMathematics, IMBM Agenda Medical problem:
More informationEditor Journal of Allergy and Therapy
Editor Journal of Allergy and Therapy Biography Prof. Domenico Ribatti was awarded his MD degree on October 1981 with full marks. His present position is of a full-time professor of Human Anatomy at the
More informationBackgrounder. 1. What are targeted therapies? 2. How do targeted therapies work?
Backgrounder TARGETED THERAPIES FOR CANCER 1. What are targeted therapies? 2. How do targeted therapies work? 3. What are some of the different types of targeted therapy? 4. What are the potential benefits
More informationGeneration of post-germinal centre myeloma plasma B cell.
Generation of post-germinal centre myeloma. DNA DAMAGE CXCR4 Homing to Lytic lesion activation CD38 CD138 CD56 Phenotypic markers Naive Secondary lymphoid organ Multiple myeloma is a malignancy of s caused
More informationANGIOPOIETIN-2 INHIBITION BY THE INVESTIGATIONAL ANG-2 ANTIBODY MEDI3617 IN RENAL CELL CARCINOMA INDUCED ANGIOGENESIS: THERAPEUTIC IMPLICATIONS
ANGIOPOIETIN-2 INHIBITION BY THE INVESTIGATIONAL ANG-2 ANTIBODY MEDI3617 IN RENAL CELL CARCINOMA INDUCED ANGIOGENESIS: THERAPEUTIC IMPLICATIONS By NIKOLETT MOLNAR A DISSERTATION PRESENTED TO THE GRADUATE
More informationThe Galectin-3 Inhibitor GR-MD-02 for Combination Cancer Immunotherapy
The Galectin-3 Inhibitor GR-MD-02 for Combination Cancer Immunotherapy Supplemental Information to Corporate Presentation February 6, 2018 NASDAQ: GALT www.galectintherapeutics.com 2018 2017 Galectin Therapeutics
More information